[Acetylsalicylic acid for prevention of colorectal adenomas. The APP Study].
Schmiegel
W
W
Medizinische Klinik der Ruhr-Universität, Knappschaftskrankenhaus Bochum. Wolff.Schmiegel@ruhr-uni-bochum.de
Reinacher-Schick
A
A
D011125:Adenomatous Polyposis Coli / Q000517:prevention & control*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage* / Q000009:adverse effects; D001241:Aspirin / Q000008:administration & dosage* / Q000009:adverse effects; D003113:Colonoscopy; D015179:Colorectal Neoplasms / Q000517:prevention & control*; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome
D000894:Anti-Inflammatory Agents, Non-Steroidal; D001241:Aspirin